FDA.reportPublic FDA data

Cimzia 200 MG Injection

RxCUI
795085
RxNorm name
Cimzia 200 MG Injection
Display name
Cimzia 200 MG Injection
Full name
Cimzia 200 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125160Cimziacertolizumab pegol351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b4c2c9dc-a0bb-4d64-a667-a67ebe88392dCimzia 200 MG Injection [PSN] · certolizumab pegol 200 MG Injection [Cimzia] [SBD] · Cimzia 200 MG Injection [SY]347These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. CIMZIA (certolizumab pegol) for injection, for subcutaneous use CIMZIA (certolizumab pegol) injection, for subcutaneous use Initial U.S. Approval: 200820260224